Epidemiology Insights and Forecast

Connect with Expert

The Epidemiology insights report provides an analysis of disease burden, characterized by disease definition, prevalence, incidence, diagnosed cases, severity, comorbidities, and clinical manifestations. Potential patient flow dynamics in disease burden are driven by shifts in demographic indicators and their correlation with age and gender distribution over time. Changes in the reported cases and long-term survival of patients may depend on diet, lifestyle, comorbid conditions, and the availability of interventions or therapies.

Key outcomes:

  • How significant are the incident/prevalent, diagnosed, and treatment-eligible patient pools for the specific country?
  • How will the patient dynamics change over a period with the availability of new interventions or therapies?
  • What are the patient segmentations by age, gender, severity level, comorbidities, line of therapies, etc.?
  • What is the relative size of patient segments and sub-populations?
  • How does the disease burden vary by country/ region?

Reports:

October 31, 2024

Market Outlook and Forecast

Iron Deficiency Anemia (IDA) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Thelansis’s “Iron Deficiency Anemia (IDA) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Iron Deficiency Anemia treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

October 16, 2024

Market Outlook and Forecast

Pulmonary Hypertension associated with Interstitial Lung Disease (PH-ILD) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Thelansis’s “Pulmonary Hypertension associated with Interstitial Lung Disease (PH-ILD) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Pulmonary Hypertension associated with Interstitial Lung Disease treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

October 22, 2024

Market Outlook and Forecast

Glycogen Storage Disease Type 1a (GSD1a) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Thelansis’s “Glycogen Storage Disease Type 1a (GSD1a) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Glycogen Storage Disease Type 1a treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

October 11, 2024

Market Outlook and Forecast

Severe Aplastic Anemia (SAA) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Thelansis’s “Severe Aplastic Anemia (SAA) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Severe Aplastic Anemia treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

October 27, 2024

Market Outlook and Forecast

Iron Overload Syndrome – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Thelansis’s “Iron Overload Syndrome Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Iron Overload Syndrome treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

October 20, 2024

Market Outlook and Forecast

Postoperative Nausea and Vomiting (PONV) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Thelansis’s “Postoperative Nausea and Vomiting (PONV) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Postoperative Nausea and Vomiting treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

Explore Reports

Need customize support?

Thelansis also caters to your specific needs by providing customized reports that satisfy your organizational requirements. Get on-demand customization of the report’s scope to exactly meet your needs.

Connect with Expert